Cargando…

Highly aggressive rat prostate tumors rapidly precondition regional lymph nodes for subsequent metastatic growth

The aim of this study was to examine in what ways MatLyLu (MLL) rat prostate tumors with high metastatic capacity influence regional lymph nodes prior to metastatic establishment compared to AT1 rat prostate tumors with low metastatic potential. MLL or AT1 tumor cells were injected into the ventral...

Descripción completa

Detalles Bibliográficos
Autores principales:	Strömvall, Kerstin, Lundholm, Marie, Thysell, Elin, Bergh, Anders, Halin Bergström, Sofia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658154/ https://www.ncbi.nlm.nih.gov/pubmed/29073272 http://dx.doi.org/10.1371/journal.pone.0187086

Ejemplares similares

Aggressive rat prostate tumors reprogram the benign parts of the prostate and regional lymph nodes prior to metastasis
por: Strömvall, Kerstin, et al.
Publicado: (2017)

Reduced number of CD169(+) macrophages in pre‐metastatic regional lymph nodes is associated with subsequent metastatic disease in an animal model and with poor outcome in prostate cancer patients
por: Strömvall, Kerstin, et al.
Publicado: (2017)

Extracellular Vesicles from Metastatic Rat Prostate Tumors Prime the Normal Prostate Tissue to Facilitate Tumor Growth
por: Halin Bergström, Sofia, et al.
Publicado: (2016)

Adaptive (TINT) Changes in the Tumor Bearing Organ Are Related to Prostate Tumor Size and Aggressiveness
por: Adamo, Hanibal Hani, et al.
Publicado: (2015)

Extratumoral Heme Oxygenase-1 (HO-1) Expressing Macrophages Likely Promote Primary and Metastatic Prostate Tumor Growth
por: Halin Bergström, Sofia, et al.
Publicado: (2016)

High Monocyte Count and Expression of S100A9 and S100A12 in Peripheral Blood Mononuclear Cells Are Associated with Poor Outcome in Patients with Metastatic Prostate Cancer
por: Åberg, Anna-Maja, et al.
Publicado: (2021)

Investigating microRNA Profiles in Prostate Cancer Bone Metastases and Functional Effects of microRNA-23c and microRNA-4328
por: Järemo, Helena, et al.
Publicado: (2023)

Rat prostate tumors induce DNA synthesis in remote organs
por: Halin Bergström, Sofia, et al.
Publicado: (2022)

Epithelial and Stromal Characteristics of Primary Tumors Predict the Bone Metastatic Subtype of Prostate Cancer and Patient Survival after Androgen-Deprivation Therapy
por: Wikström, Pernilla, et al.
Publicado: (2022)

Rat Prostate Tumor Cells Progress in the Bone Microenvironment to a Highly Aggressive Phenotype()
por: Bergström, Sofia Halin, et al.
Publicado: (2016)

Inhibition of the insulin-like growth factor-1 receptor potentiates acute effects of castration in a rat model for prostate cancer growth in bone
por: Nordstrand, Annika, et al.
Publicado: (2017)

High‐grade tumours promote growth of other less‐malignant tumours in the same prostate
por: Halin Bergström, Sofia, et al.
Publicado: (2021)

High Lysyl Oxidase (LOX) in the Non-Malignant Prostate Epithelium Predicts a Poor Outcome in Prostate Cancer Patient Managed by Watchful Waiting
por: Nilsson, Maria, et al.
Publicado: (2015)

Characterization of a Gene Expression Signature in Normal Rat Prostate Tissue Induced by the Presence of a Tumor Elsewhere in the Organ
por: Adamo, Hanibal Hani, et al.
Publicado: (2015)

Inhibition of Lysyl Oxidase and Lysyl Oxidase-Like Enzymes Has Tumour-Promoting and Tumour-Suppressing Roles in Experimental Prostate Cancer
por: Nilsson, Maria, et al.
Publicado: (2016)

Marked response to cabazitaxel in prostate cancer xenografts expressing androgen receptor variant 7 and reversion of acquired resistance by anti‐androgens
por: Ylitalo, Erik Bovinder, et al.
Publicado: (2019)

A Novel Radiographic Pattern Related to Poor Prognosis in Patients with Prostate Cancer with Metastatic Spinal Cord Compression
por: Wänman, Johan, et al.
Publicado: (2022)

Comprehensive metabolomics analysis of prostate cancer tissue in relation to tumor aggressiveness and TMPRSS2-ERG fusion status
por: Dudka, Ilona, et al.
Publicado: (2020)

Immunoreactivity for prostate specific antigen and Ki67 differentiates subgroups of prostate cancer related to outcome
por: Hammarsten, Peter, et al.
Publicado: (2019)

Prostate Cancer Metastatic to the Cervical Lymph Nodes
por: Sepúlveda, Luis, et al.
Publicado: (2015)

A novel DNA methylation signature is associated with androgen receptor activity and patient prognosis in bone metastatic prostate cancer
por: Ylitalo, Erik Bovinder, et al.
Publicado: (2021)

Size of Metastatic Lymph Nodes
por: Uriev, L., et al.
Publicado: (2013)

TMPRSS2-ERG Expression Predicts Prostate Cancer Survival and Associates with Stromal Biomarkers
por: Hägglöf, Christina, et al.
Publicado: (2014)

Lymph node metastasis‐dependent molecular classification in papillary thyroid carcinoma defines aggressive metastatic outgrowth
por: Seo, Dong Hyun, et al.
Publicado: (2023)

Progression of Papillary Thyroid Carcinoma to Anaplastic Carcinoma in Metastatic Lymph Nodes: Solid/Insular Growth and Hobnail Cell Change in Lymph Nodes Are Predictors of Subsequent Anaplastic Transformation
por: Odate, Toru, et al.
Publicado: (2021)

A case of metastatic prostate adenocarcinoma to an inguinal lymph node
por: Komeya, Mitsuru, et al.
Publicado: (2012)

Characterization of Prostate Cancer Bone Metastases According to Expression Levels of Steroidogenic Enzymes and Androgen Receptor Splice Variants
por: Jernberg, Emma, et al.
Publicado: (2013)

Lymphography in Metastatic Lymph Node Disease
por: Burn, J. I., et al.
Publicado: (1965)

Myocardial ischemic preconditioning in a porcine model leads to rapid changes in cardiac extracellular vesicle messenger RNA content()
por: Svennerholm, Kristina, et al.
Publicado: (2015)

Metastatic lymph nodes and prognosis assessed by the number of retrieved lymph nodes in gastric cancer
por: Wang, Hao, et al.
Publicado: (2022)

Number of Metastatic Lymph Nodes and Ratio of Metastatic Lymph Nodes to Total Number of Retrieved Lymph Nodes Are Risk Factors for Recurrence in Patients With Clinically Node Negative Papillary Thyroid Carcinoma
por: Zheng, Chuan-Ming, et al.
Publicado: (2018)

Clinical and biological relevance of the transcriptomic‐based prostate cancer metastasis subtypes MetA‐C
por: Thysell, Elin, et al.
Publicado: (2021)

Integrated Ratio of Metastatic to Examined Lymph Nodes and Number of Metastatic Lymph Nodes into the AJCC Staging System for Colon Cancer
por: Gao, Peng, et al.
Publicado: (2012)

Importance of Metastatic Lymph Node Ratio in Non-Metastatic, Lymph Node-Invaded Colon Cancer: A Clinical Trial
por: Isik, Arda, et al.
Publicado: (2014)

Predictors of positive axillary lymph nodes in breast cancer patients with metastatic sentinel lymph node
por: Callejo, IP, et al.
Publicado: (2005)

Rare metastasis of nasopharyngeal carcinoma to the thyroid gland with subsequent metastatic abdominal lymph nodes: A case report and literature review
por: Cai, Changjing, et al.
Publicado: (2017)

Histiocytic sarcoma of the lymph node: a rare and aggressive hematolymphoid malignancy
por: Deepa, Goel, et al.
Publicado: (2020)

Aggressive systemic mastocytosis of colon and lymph node: A case report
por: Xun-Ze, Shen, et al.
Publicado: (2023)

Bone Cell Activity in Clinical Prostate Cancer Bone Metastasis and Its Inverse Relation to Tumor Cell Androgen Receptor Activity
por: Nordstrand, Annika, et al.
Publicado: (2018)

The Microanatomic Location of Metastatic Breast Cancer in Sentinel Lymph Nodes Predicts Nonsentinel Lymph Node Involvement
por: van Deurzen, Carolien H. M., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_sfgvch84cv7lk4ib5eebq7sl1h